Researchers examined prevalence and prognostic impact of diabetes according to geographical regions and ethnicity in an observational registry of patients with chronic coronary syndromes.
A study designed to evaluate the impact of coronavirus disease 2019 lockdown on people living with type 1 diabetes, shows patients were able to improve their glycemic control indices.
About 20% of patients with diabetes hospitalized with COVID-19 die within 28 days and about 50% are discharged.
Admission-blood glucose is strong predictor of death among patients admitted directly to the intensive care unit.
The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scoring system’s utility in diagnosing necrotizing soft tissue infections of the lower extremities in patients with diabetes was assessed.
Patients with hyperglycemia and COVID-19 had higher cumulative probability of mortality.
Study authors assess the association between statin therapy and in-hospital mortality in patients with COVID-19 and concomitant diabetes mellitus.
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
Study authors investigated whether integrase strand transfer inhibitor treatment was associated with increased weight change from baseline and incident diabetes mellitus.
Researchers assessed the risk of diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with HIV in the United States and Canada.
